In this study, we manifested that TAB182 is expressed at a high level in ESCC tissues and related to patients’ poor prognosis, indicating that TAB182 is likely involved in the progression of ESCC. The gene discussed is CNOT12; the disease is esophageal squamous cell carcinoma.